Apple Settles Lawsuit With Biometric Sensor Company Valencell That Accused it of Stealing Technology for Apple Watchaccused the tech giant of stealing its technology for Apple Watch.
Valencell filed the patent infringement lawsuit against Apple back in January 2016 at the U.S. District Court for the Eastern District of North Carolina.
The lawsuit accused the Cupertino-based company of infringing on four of its patents, all related to heart rate sensing technology, as well as deceptive trade practices and breach of contract, following dealings Apple had with Valencell before the launch of the Apple Watch.
However, citing a Valencell source, well-connected endurance tech blog the5krunner reports that "Valencell's case against Apple has now been settled and neither is able to further comment."
Valencell originally claimed Apple solicited technical information and know-how under the false pretense of a licensing agreement for its PerformTek technology, despite having no real intention of actually licensing it.
The biometric company also accused Apple of deciding it was more financially beneficial to risk infringing on Valencell's patents than to license them, claiming that the practice was "consistent with the statement by Apple CEO Steve Jobs that Apple has 'always been shameless about stealing great ideas.'"
Valencell had requested a preliminary and permanent injunction preventing future acts of infringement, as well as damages and an ongoing royalty rate for licensing purposes should a permanent injunction not be granted.
Valencell provides the optical heart rate monitoring and other biometric sensors in many third party devices. The company filed a similar lawsuit against Fitbit in January 2016, but that case is said to be still ongoing.
Update: MacRumors has confirmed the lawsuit was settled in September 2018. A copy of the dismissal is embedded below.
This article, "Apple Settles Lawsuit With Biometric Sensor Company Valencell That Accused it of Stealing Technology for Apple Watch" first appeared on MacRumors.com
Discuss this article in our forums